
Novel JAK2 ингибитор, displaying significant tumor growth inhibition in SET-2 xenograft tumor model, with a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile
Novel JAK2 inhibitor, displaying significant tumor growth inhibition in SET-2 xenograft tumor model, with a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.